Business Wire

Business Wire, a wholly owned subsidiary of Berkshire Hathaway, is the global market leader in commercial news distribution.

Recent Articles By The Author

Miss HomeStreet Delivers Lightning-Fast Performance At Guntersville Hydrofest

Miss HomeStreet Delivers Lightning-Fast Performance At Guntersville Hydrofest

On the heels of winning the national championship last year, Miss HomeStreet and driver Jimmy Shane opened the H1 Unlimited season today with a 2nd-place finish at Guntersville Hydrofest.

2018 Travelers Championship Generates $1.8 Million For Charity

2018 Travelers Championship Generates $1.8 Million For Charity

The Travelers Companies, Inc. (NYSE: TRV) today announced that the 2018 Travelers Championship generated $1.

Models On PVH Rainbow-themed Double-decker Bus (Photo: Business Wire)

Models On PVH Rainbow-themed Double-decker Bus (Photo: Business Wire)

PVH Corp. [NYSE:PVH], one of the world's largest apparel companies and owner of iconic brands including  CALVIN KLEIN, TOMMY HILFIGER,  Van Heusen,  Speedo, Warner's and  IZOD, participated in today's NYC Pride March as a Platinum Level Sponsor, joining...

PPG TICKER NOTICE: Rosen Law Firm Reminds PPG Industries, Inc. Investors Of Important Deadline In First Filed Class Action- PPG

PPG TICKER NOTICE: Rosen Law Firm Reminds PPG Industries, Inc. Investors Of Important Deadline In First Filed Class Action- PPG

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of PPG Industries, Inc.

SWCH NOTICE ALERT: Rosen Law Firm Reminds Switch, Inc. Investors Of Important Deadline In Class Action - SWCH

SWCH NOTICE ALERT: Rosen Law Firm Reminds Switch, Inc. Investors Of Important Deadline In Class Action - SWCH

Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of Switch, Inc.

Insulet Presents Positive Clinical Trial Results For The Omnipod® Horizon™ Hybrid Closed-Loop System At The American Diabetes Association's 78th Scientific Sessions

Insulet Presents Positive Clinical Trial Results For The Omnipod® Horizon™ Hybrid Closed-Loop System At The American Diabetes Association's 78th Scientific Sessions

Insulet Corporation (NASDAQ:PODD) (Insulet or the Company), the leader in  tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced that positive results from the most recent clinical trial of the...

FLR ALERT NOTICE: Rosen Law Firm Reminds Fluor Corporation Investors Of Important Deadline In Case - FLR

FLR ALERT NOTICE: Rosen Law Firm Reminds Fluor Corporation Investors Of Important Deadline In Case - FLR

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fluor Corporation (NYSE: FLR) between August 14, 2013 and May 3, 2018, both dates inclusive (the "Class Period") of the important July 24, 2018 lead plaintiff...

QNST JUNE 26 NOTICE: Rosen Law Firm Reminds QuinStreet, Inc. Investors Of Important Deadline In First Filed Class Action - QNST

QNST JUNE 26 NOTICE: Rosen Law Firm Reminds QuinStreet, Inc. Investors Of Important Deadline In First Filed Class Action - QNST

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of QuinStreet, Inc.

ALGT JUNE 25 DEADLINE: Rosen Law Firm Reminds Allegiant Travel Company Investors Of Important Deadline In First Filed Class Action- ALGT

ALGT JUNE 25 DEADLINE: Rosen Law Firm Reminds Allegiant Travel Company Investors Of Important Deadline In First Filed Class Action- ALGT

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Allegiant Travel Company (NASDAQ:ALGT) from June 8, 2015 through April 13, 2018, both dates inclusive ("Class Period") of the important June 25, 2018 lead plaintiff...

Merck Presents New Data From The Comparative Trials With Sitagliptin (CompoSIT) Clinical Trial Program With JANUVIA® (sitagliptin)

Merck Presents New Data From The Comparative Trials With Sitagliptin (CompoSIT) Clinical Trial Program With JANUVIA® (sitagliptin)

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced new data from the Comparative Trials with Sitagliptin (CompoSIT) clinical trials with JANUVIA ® (sitagliptin).